The New York Times - November 19, 2022
Nir Barzilai, M.D., says the age of a candidate should not be the only factor voters consider in an election. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
National Geographic - November 2, 2022
Betsy Herold, M.D., says that long COVID symptoms that children display—including headaches, mood swings, fatigue, and abdominal pain—may be the result of COVID infection and/or a variety of other causes. Dr. Herold is chief of infectious diseases and vice chair for research in the department of pediatrics at Einstein and the Children's Hospital at Montefiore, and the Harold and Muriel Block Chair in Pediatrics at Einstein.
Dr. Herold's ProfileMore coverage on Dr. Herold
The Washington Post - November 1, 2022
Johanna Daily, M.D., M.S., notes the positive results from a study evaluating an antimalarial drug were exciting and that it can potentially play an important role in preventing infection and disease around the world. Dr. Daily is professor of medicine and of microbiology & immunology at Einstein and an infectious disease physician at Montefiore.
Additional coverage includes The Associated Press
Dr. Daily's ProfileMore coverage on Dr. Daily
MedPageToday - October 30, 2022
Fourth-year Einstein medical student Nathan Feiertag discusses his metanalysis, presented at the Sexual Medicine Society of North America's annual meeting, that indicated a link between a plant-based diet and a lower risk of prostate cancer.
The New York Times - October 25, 2022
Jill Crandall, M.D., discusses the link between statins and diabetes risk, noting that the risk is modest, but higher, for those who are prediabetic when they begin taking statins to lower their blood cholesterol levels. Dr. Crandall is professor of medicine and the Jacob A. and Jeanne E. Barkey Chair in Medicine at Einstein, and chief of endocrinology at Einstein and Montefiore.
Dr. Crandall's ProfileMore coverage on Dr. Crandall
Time - October 21, 2022
Gabriele de Vos, M.D., M.S., says immunotherapy may not be effective for some people with allergies because it is difficult to develop individual tests—and therefore treatments—to determine the specific causes of a person's allergy. Dr. de Vos is associate professor of medicine at Einstein and an allergist and immunologist at Jacobi Medical Center.
Dr. de Vos' Profile
The Wall Street Journal - October 4, 2022
Kartik Chandran, Ph.D., talks about the need for medical professionals to be ready for future outbreaks of Ebola by working on novel vaccines and drugs that are effective against numerous strains of the virus, rather than only one strain. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Faculty Scholar in Virology at Einstein.
Additional coverage includes The New York Times and Nature
Dr. Chandran's ProfileMore coverage on Dr. Chandran
Connecticut Public Radio - September 21, 2022
Sofiya Milman, M.D., M.S., discusses the SuperAgers Initiative, a study launching in October 2022 that will investigate genetic and health information to understand the science behind longevity in 10,000 people aged 95 and older in the United States. Dr. Milman is associate professor of medicine and of genetics and is director of human longevity studies at the Institute for Aging Research and an endocrinologist at Montefiore.
Dr. Milman's ProfileMore coverage on Dr. Milman
The New York Times - September 14, 2022
Shelby Freedman Harris, Psy.D., comments on the role of stress in triggering nightmares and suggests having consistent sleep and wake times to help improve the quality and duration of sleep. Dr. Harris is clinical associate professor in The Saul R. Korey Department of Neurology and of psychiatry and behavioral sciences at Einstein.
Dr. Harris's ProfileMore coverage on Dr. Harris
The New York Times - August 16, 2022
Cristina Gonzalez, M.D., M.Ed., an expert in implicit bias recognition and management, recalls the case of a young Hispanic patient whose caregivers initially doubted his pain level, which could have delayed his treatment and led to life-threatening damage. Dr. Gonzalez is professor of medicine at Einstein and a hospitalist at Montefiore.
Dr. Gonzalez's Profile
STAT News - August 9, 2022
Nir Barzilai, M.D., discusses the challenges of funding a clinical trial to test the effects of the diabetes drug metformin on delaying age-associated diseases like cancer, diabetes, and heart disease. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
NBC News - July 30, 2022
Ulrich Jorde, M.D., says the first HIV-positive to HIV positive heart transplant, performed at Montefiore, is a milestone in the history of organ donation. Dr. Jorde is professor of medicine at Einstein and head of heart failure, cardiac transplantation & mechanical circulatory support and vice chief of the division of cardiology at Montefiore.
Dr. Jorde's Profile
BronxNet - July 27, 2022
Balazs Halmos, M.D., discusses a grant that will enable the Montefiore Einstein Cancer Center to improve lung cancer care for underserved minority patients. Dr. Halmos is professor of medicine at Albert Einstein College of Medicine and associate director of clinical science at the Montefiore Einstein Cancer Center.
Dr. Halmos' ProfileMore coverage on Dr. Halmos
Medscape - July 26, 2022
Robert Grossberg, M.D., comments on an analysis that found certain anti-viral treatments for COVID-19 may help patients avoid hospitalization or death, but notes that the studies were done only in unvaccinated participants and before the Omicron variant emerged. Dr. Grossberg is associate professor of medicine at Einstein and an infectious disease physician at Montefiore.
Dr. Grossberg's Profile
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is professor and chair of ophthalmology and visual sciences and the Paul Henkind Chair in Ophthalmology at Einstein and Montefiore.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons
August 27, 2012
American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center.
Dr. Marion's ProfileMore coverage on Dr. Marion
April 25, 2012
The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein.
March 13, 2012
New Scientist interviews Vern Schramm, Ph.D., about his research on transition state analogs, a class of drugs he has been developing that target and neutralize specific enzymes in order to combat disease. Dr. Schramm is professor and Ruth Merns Chair in Biochemistry at Einstein.
Dr.Schramm's ProfileMore coverage on Dr.Schramm
February 1, 2012
Arthritis Today interviews Dr. Anna Broder regarding her research that found continued treatment may help extend the lives of lupus patients with end-stage renal disease. Dr. Broder is assistant professor of medicine.
Dr.Broder's ProfileMore coverage on Dr.Broder
Newsweek - February 1, 2012
Microbe features research by Liise-Anne Pirofski , M.D., about a newly identified antibody that works against pneumococcal bacteria and could help to improve vaccines against pneumonia. Dr. Pirofski is chief of the division of infectious diseases at Einstein and Montefiore Medical Center and the Selma and Dr. Jacques Mitrani Professor in Biomedical Research.
Dr.Pirofski's ProfileMore coverage on Dr.Pirofski